Aβ42 fibril formation from predominantly oligomeric samples suggests a link between oligomer heterogeneity and fibril polymorphism
Amyloid-β (Aβ) oligomers play a central role in the pathogenesis of Alzheimer's disease. Oligomers of different sizes, morphology and structures have been reported in both in vivo and in vitro studies, but there is a general lack of understanding about where to place these oligomers in the over...
Main Authors: | Christine Xue, Joyce Tran, Hongsu Wang, Giovanna Park, Frederick Hsu, Zhefeng Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
The Royal Society
2019-07-01
|
Series: | Royal Society Open Science |
Subjects: | |
Online Access: | https://royalsocietypublishing.org/doi/pdf/10.1098/rsos.190179 |
Similar Items
-
α-Synuclein oligomers and fibrils: partners in crime in synucleinopathies
by: Alessandra Bigi, et al.
Published: (2023-01-01) -
Site-specific structural order in Alzheimer's Aβ42 fibrils
by: Hongsu Wang, et al.
Published: (2018-01-01) -
Nanobodies raised against monomeric ɑ-synuclein inhibit fibril formation and destabilize toxic oligomeric species
by: Marija Iljina, et al.
Published: (2017-07-01) -
S100B chaperone multimers suppress the formation of oligomers during Aβ42 aggregation
by: António J. Figueira, et al.
Published: (2023-03-01) -
Amyloid oligomers as on-pathway precursors or off-pathway competitors of fibrils
by: Martin Muschol, et al.
Published: (2023-02-01)